← All diseases
Muscles and connective tissue
Systemic sclerosis (scleroderma)
Do you want to receive a message when there is new research about Systemic sclerosis (scleroderma)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a summary sentence appears above each publication explaining what was studied — and you'll receive notification as soon as new research on Systemic sclerosis (scleroderma) is published. View what Premium costs.
Publications and studies (2095)
- Identification of Autoimmunity to Peptides of Collagen V α1 Chain as Newly Biomarkers of Early Stage of Systemic Sclerosis. (2021/02/12) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus. (2021/02/03) ♡
- Gastrointestinal involvement in systemic sclerosis: Effects on morbidity and mortality and new therapeutic approaches. (2021/02/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Systemic sclerosis overlap and non-overlap syndromes share clinical characteristics but differ in prognosis and treatments. (2021/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Thymoquinone in autoimmune diseases: Therapeutic potential and molecular mechanisms. (2021/02/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Quantitative evaluation of callosal abnormalities in relapsing-remitting multiple sclerosis using diffusion tensor imaging: A systemic review and meta-analysis. (2021/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Use of nintedanib in interstitial lung disease other than idiopathic pulmonary fibrosis: much caution is warranted. (2021/02/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature. (2021/02/01) ♡
- Use of vonoprazan for management of systemic sclerosis-related gastroesophageal reflux disease. (2021/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The rationale for targeting the JAK/STAT pathway in scleroderma-associated interstitial lung disease. (2021/02/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Are troponin and B-type natriuretic peptides useful biomarkers for the diagnosis of systemic sclerosis heart involvement? A systematic literature review. (2021/02/01) ♡
- Overall mortality. (2021/02/01) ♡
- Mortality and morbidity in scleroderma renal crisis: A systematic literature review. (2021/02/01) ♡
- Mycophenolic acid drug monitoring in patients with systemic sclerosis associated with diffuse skin and/or pulmonary involvement: A monocentric and retrospective French study. (2021/02/01) ♡
- Requirements for systemic sclerosis expert centres in the Netherlands: A Delphi consensus study. (2021/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. COVID-19 and systemic sclerosis: Rising to the challenge of a pandemic. (2021/02/01) ♡
- Impact of COVID-19 on outpatient therapy with iloprost for systemic sclerosis digital ulcers. (2021/02/01) ♡
- Comparing paediatric- and adult-onset linear morphoea in a large tertiary-referral scleroderma centre. (2021/02/01) ♡
- Hematopoietic stem cell transplantation in systemic sclerosis: Yes!! BUT. . (2021/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The multifaceted problem of pulmonary arterial hypertension in systemic sclerosis. (2021/02/01) ♡
- Update on Morbidity and Mortality in Systemic Sclerosis-Related Interstitial Lung Disease. (2021/02/01) ♡
- Advances at the Interface of Cancer and Systemic Sclerosis. (2021/02/01) ♡
- Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes. (2021/02/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Thyroid Warthin-Like Cancer Concurrent With Multiple Sclerosis: A Case Report. (2021/02/01) ♡
- Mast Cell Activation in the Systemic Sclerosis Esophagus. (2021/02/01) ♡
- Optic Perineuritis and Its Association With Autoimmune Diseases. (2021/01/29) ♡
- Finger sweating levels evaluated by video capillaroscopy system are increased in patients with systemic sclerosis compared to pre-clinical stage patients. (2021/01/23) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial: Interstitial Lung Disease in the Context of Systemic Disease: Pathophysiology, Treatment and Outcomes. (2021/01/20) ♡
- From a Designer Drug to the Discovery of Selective Cannabinoid Type 2 Receptor Agonists with Favorable Pharmacokinetic Profiles for the Treatment of Systemic Sclerosis. (2021/01/14) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Epstein-Barr Virus and Systemic Autoimmune Diseases. (2021/01/07) ♡
- Adipose tissue is a critical regulator of osteoarthritis. (2021/01/05) ♡
- Epidemiological profile of systemic sclerosis in the southeast region of Romania. (2021/01/01) ♡
- Etiological factors of systemic sclerosis in the southeast region of Romania. (2021/01/01) ♡
- Development of a Musculoskeletal Ultrasound Protocol to Examine Upper Extremity Rehabilitation Outcomes in Systemic Sclerosis. (2021/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Autoimmune connective tissue diseases in the COVID-19 pandemic. (2021/01/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Ethnicity-based differences in the incident risk of allergic diseases and autoimmune disorders: A UK-based retrospective cohort study of 4.4 million participants. (2021/01/01) ♡
- Lifestyle and Mediterranean diet adherence in a cohort of Southern Italian patients with Multiple Sclerosis. (2021/01/01) ♡
- [Endoscopic closure of an esophago-pleural fistula resulting from a perforated esophageal ulcer due to systemic sclerosis: filling and shielding using polyglycolic acid sheets and fibrin glue]. (2021/01/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Individuality of the composition of the human microbiota. (2021/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Indications, effectiveness and safety of percutaneous endoscopic gastrostomy: A single center experience and literature review. (2021/01/01) ♡
- The Importance of Diagnostic and Prognostic Biomarker Identification and Classification Towards Understanding ALS Pathogenesis. (2021/01/01) ♡
- Juvenile systemic sclerosis - observations of one clinical centre. (2021/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Search for Diagnostic and Prognostic Biomarkers in Systemic Sclerosis and Inflammatory Myopathies (2021-12-15) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Evaluation of Effectiveness of Acetylsalicylic Acid on Markers of Vascular Dysfunction in Scleroderma Patients (2021-12-01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Novel Screening Strategies for Scleroderma PAH (2021-11-15) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Evaluation of Slit2 in Systemic Lupus Erythematosus and Systemic Sclerosis Patients (2021-11-03) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. What is the Optimal Follow-up for Patients With Systemic Sclerosis? (2021-11-02) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Scleroderma (2021-10-20) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Effects of Telerehabilitation Based Exercise Program in Patients With Systemic Sclerosis (2021-10-14) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD (2021-10-07) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.